The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

G Conway, D Dewailly… - European journal of …, 2014 - academic.oup.com
Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society

HF Escobar-Morreale, E Carmina… - Human reproduction …, 2012 - academic.oup.com
BACKGROUND Hirsutism, defined by the presence of excessive terminal hair in androgen-
sensitive areas of the female body, is one of the most common disorders in women during …

Polycystic ovary syndrome

DA Ehrmann - New England Journal of Medicine, 2005 - Mass Medical Soc
The polycystic ovary syndrome is one of the most common hormonal disorders affecting
women. It has multiple components—reproductive, metabolic, and cardiovascular—with …

[HTML][HTML] Day–night pattern of sudden death in obstructive sleep apnea

AS Gami, DE Howard, EJ Olson… - New England Journal of …, 2005 - Mass Medical Soc
Background The risk of sudden death from cardiac causes in the general population peaks
from 6 am to noon and has a nadir from midnight to 6 am Obstructive sleep apnea is highly …

[HTML][HTML] Hormonal therapies and venous thrombosis: Considerations for prevention and management

C LaVasseur, S Neukam, T Kartika, BS Bannow… - Research and Practice …, 2022 - Elsevier
Background Venous thromboses are well‐established complications of hormonal therapy.
Thrombosis risk is seen with both hormonal contraceptive agents and with hormone …

Hirsutism, normal androgens and diagnosis of PCOS

PM Spritzer, LB Marchesan, BR Santos, TM Fighera - Diagnostics, 2022 - mdpi.com
Hirsutism is defined as the presence of terminal hair with male pattern distribution in women.
While in the general population, hirsutism affects around 4–11% of women, it is the main …

Combined oral contraceptives in the treatment of polycystic ovary syndrome

J Vrbikova, D Cibula - Human reproduction update, 2005 - academic.oup.com
Combined oral contraceptives (COC) are the most often used treatment modality for
polycystic ovary syndrome (PCOS). Undisputedly, COC suppress androgen production, thus …

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

A Bargiota… - Therapeutic advances in …, 2012 - journals.sagepub.com
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of
reproductive age that is associated with significant adverse short-and long-term health …

Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients

G Monastra, V Unfer, AH Harrath… - Gynecological …, 2017 - Taylor & Francis
Polycystic ovary syndrome (PCOS), a relevant cause of infertility, is a heterogeneous,
endocrine disorder affecting up to 10–15% of women in reproductive age. Besides …

[HTML][HTML] Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with …

SM Bhattacharya, A Jha - Fertility and sterility, 2012 - Elsevier
OBJECTIVE: To compare the effects of oral contraceptive pills containing desogestrel,
cyproterone acetate, and drospirenone, in polycystic ovary syndrome (PCOS), after 6 and 12 …